The NWHN’s Statement on the FDA Ordering Manufacturers of Surgical Mesh to Stop Selling Devices for Uterine Prolapse
FOR IMMEDIATE RELEASE Contact: Evita Almassi, email@example.com or (202) 682-6240
In 2016, the FDA reclassified transvaginal mesh used to repair pelvic organ prolapse (POP) as a Class III device—the highest risk category—in response to over 20,000 adverse event reports during a three-year period alone.
Testimony Delivered at the Meeting of the FDA Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee
If you’ve been diagnosed with pelvic organ prolapse (POP), you are far from alone: research indicates up to 50 percent of women over the age of 50 experience POP, which occurs when organs sag or fall into the vaginal canal because of weakened pelvic muscles.